Cargando…
Impfstoffe gegen „coronavirus disease 2019“ (COVID-19): Wirksamkeitsvergleich, Sicherheitsaspekte und aktuelle Herausforderungen
Several RNA-, vector-, and protein-based coronavirus disease 2019 (COVID-19) vaccines are currently available in order to achieve high titers of neutralizing antibodies against the spike protein as well as strongly activated CD4+- and CD+ T‑cells. However, there are formulation-specific advantages a...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092324/ https://www.ncbi.nlm.nih.gov/pubmed/35543726 http://dx.doi.org/10.1007/s00108-022-01325-9 |